ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD

The Phase IV, 8-week, randomized, double-blind, placebo-controlled ACTIVATE study (NCT02424344) evaluated the effect of aclidinium/formoterol (AB/FF) 400/12 μg twice daily on lung hyperinflation, exercise capacity, and physical activity in patients with moderate-to-severe COPD. Patients received AB/...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Chron Obstruct Pulmon Dis
Главные авторы: Watz, Henrik, Troosters, Thierry, Beeh, Kai M, Garcia-Aymerich, Judith, Paggiaro, Pierluigi, Molins, Eduard, Notari, Massimo, Zapata, Antonio, Jarreta, Diana, Garcia Gil, Esther
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2017
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574699/
https://ncbi.nlm.nih.gov/pubmed/28883722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S143488
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы